5th May
On-Site (Hyatt Regency & Residences, Pune, India)


Pall Corporation provides critical filtration, separation, and purification solutions to meet the demanding needs of a broad spectrum of life sciences and industrial customers around the globe. Across 80 locations and 10,000 people worldwide, we are unified by a singular drive: to solve our customers' biggest fluid management challenges. And in doing so advance health, safety, and environmentally responsible technologies. Together, our Life Sciences and Industrial teams serve a diverse range of customers including biotechnology, pharmaceutical, medical, food and beverage, laboratory, microelectronics, aerospace, fuels, petrochemical, chemical, automotive and power generation industries. Our industry-leading technologies and solutions are at work in countless applications, protecting critical operating assets, improving product quality, safeguarding the health, and minimizing emissions and waste
For more info, please check: https://www.pall.com/en/biotech.html

Ami Polymer Pvt. Ltd. is one of the leading manufacturers and suppliers of Biopharmaceuticals and silicone-based products in India . Established in the year 1998 in Mumbai, India, our company has been acclaimed for quality and excellence in the range of products offered. We employ efficient supply chain management system and have committed ourselves to deliver the finest products on time to our valuable customers.
We are an ISO 9001:2015,ISO 14001:2015 & ISO 45000-2018 ,TUV Nord Certified company, having a cleanroom of 25000 sq. feet area, supplying the finest quality range of biopharmaceuticals grade Elastomer Tubing, Reinforced Hoses, Inflatable Gaskets, Extruded & moulded components and single use assemblies as per USFDA standards.
Know more about us at :- www.amipolymer.com
Primary Contact :- Mr. Chandan S./Mrs. Aswathy Nair
Email id :- [email protected]/[email protected]
Designation :- Sr. Manager Business Devlopment / Sr. Executive International Marketing



India Biologics and Vaccines Outstanding Industry Awards (BVOIA) 2022 seeks to give recognition to exceptional biologics and vaccine experts, organizations and technologies that facilitate vaccine R&D and biologics manufacturing excellence at enhanced speed, reduced cost, and superior quality. Featuring top vaccine and biomanufacturing leaders in the industry, along with the latest advances in technologies and best practices in R&D and manufacturing, the India Biologics and Vaccines Outstanding Achievement Award 2022 applauds extraordinary leaders & trend-setters of today and inspires innovators of tomorrow.

Ranjan Chakrabarty
Dr. Ranjan Chakrabarti, former Vice President–Global Biologics at United States Pharmacopeia has over 33years of experience in Pharmaceutical and Biopharma industries. Before joining USP, Dr. Ranjan was leading the Biology Group at Dr. Reddy’s Drug discovery and also served at key management position in GVK Biosciences. He has worked with several National and International companies for discovery and development of both chemical and biological molecules. Before joining to Industry, he worked 7 years in Academics at USA and successfully coordinated research projects in Cancer Cell Biology and Diabetes. He has guided several Ph. D. students. Dr. Ranjan is the Co-Inventor of 32 US Patents; published 62papers in peer reviewed International Journals and presented 96lectures in International and National Conferences.

Rajinder Kumar Suri

Shashwati Basak Phd
Dr Shashwati Basak has a PhD in Molecular and Cell Biology and two postdoctoral fellowships in gene expression, regulation and cancer signalling pathways from Salk Institute for Biological Sciences and Stanford University. She has 20+ years of scientific leadership experience in translational research, clinical biomarkers, analytical assays and technology platforms. She has worked in several Biotech / Biopharma companies including Biocon Bristol Myers-Squibb R & D center, Aurigene Discovery Technologies and Immuneel Therapeutics Ltd and held positions of increasing responsibilities, in varied roles. Currently, as an Independent Consultant, her focus is on various aspects of drug development, especially in Cell and Gene Therapy, including Quality and Compliance in CGT.

Raj Shankar Ghosh

JNC CORPORATION / MR SANGHAVI & CO. We are in the business of providing Biotech, Pharma, Fine Chemicals & Academia solutions. With state of the art chromatography bulk media, resins, gels & equipment’s from the world’s best companies, we offer the best technical solutions & support. The Cellufine™ product line offers a broad range of chromatography resins for the purification of proteins, enzymes, and biomolecules. The media based on spherical cellulose beads, exhibits high chemical stability / mechanical strength, higher flux and inherently bio-compatible. Applications include protein / polysaccharide purification, endotoxin removal, and used worldwide purifying vaccines, therapeutic enzymes, and virus concentration / purification. Cellulose media have significantly lower Leachable than comparable polymeric beads. Gel Filtration, IEX, Affinity, and HIC media available for broad range of biomolecules and applications. Cellufine customizes media / ligands, bead sizes for challenging purification process. Besides growing and consolidating the business of international marketing of industrial products and chemical specialties, we undertake backward/forward integration activity to produce tailor-made value-added specialty products. “Our mission is to become a benchmark organization in this line of business by striving consistently to develop our organization, professional skills & infrastructure as to be highly effective in this competitive environment.” Mr. Rajiv Sanghavi Director JNC CORPORATION/MR SANGHAVI & CO. 28, Sarvodaya Industrial Estate, Near Paper Box, Off. Mahakali Caves road, Andheri East, Mumbai – 400093 Mobile : +91-9323990409 Email : [email protected] Website : www.mrsanghavico.com

JNC CORPORATION / MR SANGHAVI & CO. We are in the business of providing Biotech, Pharma, Fine Chemicals & Academia solutions. With state of the art chromatography bulk media, resins, gels & equipment’s from the world’s best companies, we offer the best technical solutions & support. The Cellufine™ product line offers a broad range of chromatography resins for the purification of proteins, enzymes, and biomolecules. The media based on spherical cellulose beads, exhibits high chemical stability / mechanical strength, higher flux and inherently bio-compatible. Applications include protein / polysaccharide purification, endotoxin removal, and used worldwide purifying vaccines, therapeutic enzymes, and virus concentration / purification. Cellulose media have significantly lower Leachable than comparable polymeric beads. Gel Filtration, IEX, Affinity, and HIC media available for broad range of biomolecules and applications. Cellufine customizes media / ligands, bead sizes for challenging purification process. Besides growing and consolidating the business of international marketing of industrial products and chemical specialties, we undertake backward/forward integration activity to produce tailor-made value-added specialty products. “Our mission is to become a benchmark organization in this line of business by striving consistently to develop our organization, professional skills & infrastructure as to be highly effective in this competitive environment.” Mr. Rajiv Sanghavi Director JNC CORPORATION/MR SANGHAVI & CO. 28, Sarvodaya Industrial Estate, Near Paper Box, Off. Mahakali Caves road, Andheri East, Mumbai – 400093 Mobile : +91-9323990409 Email : [email protected] Website : www.mrsanghavico.com

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of lifesaving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 40 billion components and devices each year.
Headquartered in Exton, Pennsylvania, and in business for nearly a century, West in its fiscal year 2020 generated over $2.147 billion in annual revenue. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

The world’s first “Vial-to-Harvest” Vaccine manufacturing platform with Linear scalability & ultimate process efficiency.
With decades of developmental efforts & experience in Bioprocess Engineering, we have solved the most critical problems of adherent cell culture processing i.e. 1) Lack of process scalability 2) Efficiency in terms of time to market 3) Affordability in terms of cost reduction in manufacturing process.
At OmniBRx, we have invented a novel bioreactor technology for large-scale biologics / vaccines production and stem-cell therapy use. The technology provides 10X Scalability, 6X efficiency and up to 90% cost reduction during upstream manufacturing processing.
Our patented “CellBRx®️” single-use bioreactors technology is the first-of-its-kind bioreactor devices offering a fully automated and robust platform for vaccine manufacturing with linear scalability of up to 200L bioreactor volume accommodating 1500 m2 of surface area per single-use bioreactor. The proprietary DBR technology employs parallel discs stacked on multiple shafts and the intermingling rotational arrangement of the discs ensures efficient mixing and homogeneity throughout the cell carrier matrix.
With the integrated seed-train development protocol, the technology becomes the first ever close-circuit fully-automated Vial-to-Harvest production platform. The CellBRx bioreactors can grow cells in high densities and recover them efficiently with complete end-to-end process automation.

Peli BioThermal is the first cold chain packaging solutions provider to make available a broad and comprehensive portfolio of patented and award-winning single-use and reusable thermal protection packaging solutions for the safe transport of pharmaceuticals, clinical trials, diagnostics, tissue, vaccines and blood supplies for the life science industry.
Collaboration with our clients is the first step to ensure we provide a solution that is built around the unique and very specific needs of your temperature-sensitive payloads. Our global services network provides consultation, support, engineering and deployment for your cold chain distribution challenges wherever they exist.
Peli BioThermal designs products to ensure our customers valuable payloads are kept in perfect condition, irrespective of external temperatures and conditions. They are designed to be strong and robust, to survive the rigors of international transport. With environmental issues in mind, we ensure that our design team specify the correct materials and consider ‘end of life’ recycling for all of our ranges, whether they are single use or reusable packaging systems.

HiMedia Laboratories Private Limited is an Indian origin Bioscience company headquartered in Mumbai, with presence across 150 countries. Its division, Animal Cell Culture has expertise in production of cell culture medium for mammalian & insect cell lines, in powdered and liquid formulations. Comprehensive design of experiments, raw material qualification and media production using automation and customization are our strengths. We supply serum free media for CHO, Vero, MDCK, HEK, PK-15, Vero, MRC-5 and BHK cell lines, most widely used for industrial production of recombinant proteins and vaccines. In addition, we also supply multi-compendial biochemicals and growth factors for Cell Culture.
To know more about our company please visit our website: www.himedialabs.com

Marken is a wholly owned subsidiary of UPS and is a critical part of UPS Healthcare. With Polar Speed and Marken included, the UPS Healthcare division staffs 128 locations with 5,500 employees worldwide. Marken offers a state-of-the-art GMP-compliant depot network and logistic hubs for clinical drug product storage and distribution in 59 locations worldwide, while maintaining the leading position for Direct-to-Patient and Home Healthcare services, biological sample shipments and biological kit production.
Marken’s dedicated 2,000 staff members manage 135,000 drug product and biological sample shipments every month at all temperature ranges in more than 220 countries and territories and have orchestrated 11,500+ home healthcare visits. Additional services such as cell and gene supply chain services, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.
Website: https://www.marken.com/


- The 3M biopharmaceutical business is a subset of the 3M Separation and Purification Sciences Division which utilizes cutting edge 3M material science that pushes the boundaries of purification, filtration, and separation to support production, processes that change lives, and deliver quality solutions where it matters most.
- Our biopharma and materials science expertise can help you improve in-process purity, increase the yield of your product and lower manufacturing costs – so you can focus on bringing life-saving treatments to trial and market
- Biopharmaceutical Purification | 3M

A world leader in the design and manufacture of high-performance temperature-controlled packaging systems for the transport of pharmaceutical products, EMBALL’ISO is now an expert of turnkey Reuse, Reverse Logistics and Rental solutions.
EMBALL’ISO’s worldwide presence across 4 continents, with 8 production sites (Brazil, China, France, Germany, India, Singapore, UK and the US), 14 Services Centre and collection points in more than 80 countries helps you reuse isothermal packaging while saving time and money.
We supply systems capable of carrying a single vial to airfreight pallet shippers available flat packed or fully assembled in new and innovative Logistics Business models.
EMBALL’ISO delivers quality everywhere, just like you.

Pfanstiehl is the market leader of high purity, low endotoxin, low metal excipients for biologics, biosimilars, vaccines, cell culture media and injectable (liquid and lyophilized) formulations and supplies its products to nearly all leading global biopharmaceutical companies.
Pfanstiehl was founded in 1919 and currently celebrating its 103rd anniversary year in 2022. Pfanstiehl is headquartered at Waukegan, IL, USA and has diverse global technical support team across the globe in USA, Europe & APAC.
Pfanstiehl has manufactured parenteral grade excipients for more than 50 years, and Pfanstiehl’s high purity, low endotoxin and low metal excipient products are known as “best in class” due to their high characterization, performance, consistency, and quality attributes.
Pfanstiehl’s excipients are critical components in the majority of the global blockbuster biopharmaceutical drugs and vaccines including majority of the Covid -19 vaccines that were administered globally.
For more information about Pfanstiehl Inc, and their products and solutions, please contact us at [email protected] or visit www.Pfanstiehl.com

Pfanstiehl is the market leader of high purity, low endotoxin, low metal excipients for biologics, biosimilars, vaccines, cell culture media and injectable (liquid and lyophilized) formulations and supplies its products to nearly all leading global biopharmaceutical companies.
Pfanstiehl was founded in 1919 and currently celebrating its 103rd anniversary year in 2022. Pfanstiehl is headquartered at Waukegan, IL, USA and has diverse global technical support team across the globe in USA, Europe & APAC.
Pfanstiehl has manufactured parenteral grade excipients for more than 50 years, and Pfanstiehl’s high purity, low endotoxin and low metal excipient products are known as “best in class” due to their high characterization, performance, consistency, and quality attributes.
Pfanstiehl’s excipients are critical components in the majority of the global blockbuster biopharmaceutical drugs and vaccines including majority of the Covid -19 vaccines that were administered globally.
For more information about Pfanstiehl Inc, and their products and solutions, please contact us at [email protected] or visit www.Pfanstiehl.com

Nanghavi is a Joint Venture between Sweden based R&D company Nanologica and an Indian family owned business by the Sanghavi family, thereby deriving the name “NANGHAVI”.
We are in the business of manufacturing Analytical, Semi Preparative and Prep HPLC columns by. Our in-house capabilities boasts of manufacturing the silica, functionalizing it, packing the HPLC column & marketing and selling them.
We have an end-to-end capability of manufacturing from the raw material of spherical silica to the HPLC columns itself, we can have complete control over quality of the end product.

Ami Polymer Pvt. Ltd. is one of the leading manufacturers and suppliers of Biopharmaceuticals and silicone-based products in India . Established in the year 1998 in Mumbai, India, our company has been acclaimed for quality and excellence in the range of products offered. We employ efficient supply chain management system and have committed ourselves to deliver the finest products on time to our valuable customers.
We are an ISO 9001:2015,ISO 14001:2015 & ISO 45000-2018 ,TUV Nord Certified company, having a cleanroom of 25000 sq. feet area, supplying the finest quality range of biopharmaceuticals grade Elastomer Tubing, Reinforced Hoses, Inflatable Gaskets, Extruded & moulded components and single use assemblies as per USFDA standards.
Know more about us at :- www.amipolymer.com
Primary Contact :- Mr. Chandan S./Mrs. Aswathy Nair
Email id :- [email protected]/[email protected]
Designation :- Sr. Manager Business Devlopment / Sr. Executive International Marketing



5th Annual Vaccine World Asia Congress 2023

28/11/2023

Marina Bay Sands Expo & Convention Centre, Singapore

7th Annual Cell & Gene Therapy World Asia 2023

14/09/2023

Equarius Hotel, Resorts World Sentosa, Singapore